Search results
Results from the WOW.Com Content Network
The common side effects of this combination are those of its individual drugs. For instance, the use of inhaled corticosteroids is associated with oral candidiasis, commonly known as yeast infection or thrush.
The discontinuation aligns with a change to Medicaid rebates that may have had the inhaler’s manufacturer selling the drug at a loss. Popular asthma inhaler will be discontinued Jan. 1. Here’s ...
The company discontinued ... Diskus incorporating Pfizer's proprietary dry powder inhaler ... In January 2019, the FDA announced its approval of the company's Wixela ...
Drugs or medicines may be withdrawn from commercial markets because of risks to patients, but also because of commercial reasons (e.g. lack of demand and relatively high production costs).
Flovent, one of the most commonly prescribed childhood asthma inhalers, is no longer being manufactured in the United States. This preventative medication is usually taken every day to help keep ...
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.
Inhalers: Fluticasone furoate is commonly available in the form of a dry powder inhaler (DPI) for inhalation. This inhaler is used for the maintenance treatment of asthma in patients aged 12 years and older. It delivers the medication directly to the lungs, where it acts to reduce inflammation and improve asthma symptoms. [15]
Previously used metered-dose inhaler of Serevent-brand salmeterol A typical dry-powder inhaler salmeterol "diskus" Salmeterol, first marketed and manufactured by Glaxo (now GlaxoSmithKline, GSK) in the 1980s, was released as Serevent in 1990. [6] The product is marketed by GSK under the Allen & Hanburys brand in the UK. [citation needed]